Latest Production News

Generation Development Group reports a transformative FY25 with record Investment Bond sales and successful integration of Evidentia and Lonsec managed accounts, setting the stage for strong growth in FY26.

Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.

Magnetic Resources NL’s Feasibility Study confirms a robust standalone development for its Lady Julie Gold Project in Western Australia, projecting over 1 million ounces of gold production across nine years with strong financial returns.

Asra Minerals has confirmed significant high-grade gold mineralisation at its Gladstone prospect, extending known deposits deeper than previously recorded. These results bolster the Leonora South Gold Project’s resource potential and set the stage for expanded exploration.

Vulcan Energy has won up to €104 million in grants from German federal and state governments to advance its sustainable lithium production project, bolstering Europe’s electric vehicle battery supply chain.

Spartan Resources Limited shares have been suspended from the ASX following court approval of a scheme of arrangement for its acquisition by Ramelius Resources Limited. This marks a significant step toward the consolidation of gold mining assets in Western Australia.

Nordic Resources has completed a major acquisition of three advanced gold projects in Finland, lifting its total gold equivalent resources to 1.23 million ounces. The company also secured A$3.5 million in institutional funding and appointed a seasoned mining executive as Chairman.

Polymetals Resources has updated its June 2025 quarterly cash flow report, confirming nearly two quarters of funding and ongoing revenue from concentrate sales. The company’s financing position remains stable amid planned equity issuance.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.

Bod Science reports a solid net cash inflow of $858,000 in Q4 FY2025, driven by R&D incentives and Biortica funding, while awaiting shareholder approval to complete a key acquisition.

Nico Resources Limited reported steady progress on its Wingellina nickel-cobalt project despite challenging market conditions, completing a $1.1 million share placement and advancing metallurgical and drilling programs.

Kingsland Minerals has withdrawn its previously implied production target for the Leliyn Graphite Project’s processing plant, citing non-compliance with ASX disclosure rules and advising investors to disregard prior estimates.